Anna Aillerie, Head Of Commercial Operations, Biotechnology Business Unit at Gedeon Richter
Gedeon Richter Logo

Anna Aillerie


Head Of Commercial Operations, Biotechnology Business Unit
Gedeon Richter
Biosimilars Commercialisation Summit Agenda 2019

Biosimilars Commercialisation Summit Agenda 2019

View Content

Conference Day One

Wednesday, February 5th, 2020


2:05 PM Case Study: Launching a Biosimilar into the European Marketplace in 2019

  • Explore the current European market place by analysing the successes and failures of Big Pharma and SMEs  in their approach to  biosimilar commercialisation 
  • Benchmark your branding practice and commercial strategy against the challenges and opportunities encountered in the preparation for launch of a new biosimilar 
  • Get a sneak peek into pre-marketing and marketing activities around a launch of a new biosimilar into the European market  

5:40 PM Panel Discussion: Boosting Patient Access to Biosimilars In Europe

  • Explore the need for collaboration between Payers, Regulators and Industry to enhance patient access to biosimilars in Europe
  • Consider how policy can be utilized as a tool to broaden patient access
  • What does the future hold for the stability of the Biosimilars Market in the EU?

Check out the incredible speaker line-up to see who will be joining Anna.

Download The Latest Agenda